OTCMKTS:CBSC

CB Scientific - CBSC Competitors

$0.19

0.00 (0.00%)

(As of 10/3/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.19
▼
$0.19
50-Day Range: $0.14
▼
$0.27
52-Week Range: $0.11
▼
$0.95

Volume: N/A
Average Volume: 18,076 shs
Market Capitalization: $22.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

CBSC vs. SRGA, ONCR, BCAC, EFTR, ATNF, ATBPF, TNXP, ACER, ALRT, and RGRX

Should you be buying CB Scientific stock or one of its competitors? The main competitors of CB Scientific include Surgalign (SRGA), Oncorus (ONCR), Brookline Capital Acquisition (BCAC), eFFECTOR Therapeutics (EFTR), 180 Life Sciences (ATNF), Antibe Therapeutics (ATBPF), Tonix Pharmaceuticals (TNXP), Acer Therapeutics (ACER), ALR Technologies (ALRT), and RegeneRx Biopharmaceuticals (RGRX). These companies are all part of the "medical" sector.

CB Scientific vs.

Surgalign (NASDAQ:SRGA) and CB Scientific (OTCMKTS:CBSC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, community ranking, analyst recommendations, profitability and valuation.

: Surgalign has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500. Comparatively, CB Scientific has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500.
: In the previous week, Surgalign had 3 more articles in the media than CB Scientific. MarketBeat recorded 4 mentions for Surgalign and 1 mentions for CB Scientific. CB Scientific's average media sentiment score of 0.99 beat Surgalign's score of 0.37 indicating that CB Scientific is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgalign
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CB Scientific
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: CB Scientific has a net margin of 0.00% compared to Surgalign's net margin of -70.49%. CB Scientific's return on equity of 0.00% beat Surgalign's return on equity.
Company Net Margins Return on Equity Return on Assets
Surgalign -70.49% -234.38% -47.02%
CB Scientific N/A N/A N/A
: 14.9% of Surgalign shares are held by institutional investors. 10.3% of Surgalign shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: Surgalign presently has a consensus price target of $48.75, suggesting a potential upside of 1,203.48%. Given Surgalign's higher probable upside, equities analysts clearly believe Surgalign is more favorable than CB Scientific.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgalign
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
CB Scientific
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: CB Scientific has lower revenue, but higher earnings than Surgalign.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Surgalign $90.50 million 0.28 -$84.65 million -$12.57 -0.30
CB Scientific N/A N/A N/A N/A N/A
: Surgalign received 9 more outperform votes than CB Scientific when rated by MarketBeat users.
Company Underperform Outperform
Surgalign Outperform Votes
9
50.00%
Underperform Votes
9
50.00%
CB Scientific N/A N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Surgalign	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CB Scientific	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Surgalign	-70.49%	-234.38%	-47.02%
CB Scientific	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Surgalign	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
CB Scientific	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surgalign	$90.50 million	0.28	-$84.65 million	-$12.57	-0.30
CB Scientific	N/A	N/A	N/A	N/A	N/A

Company	Underperform	Outperform
Surgalign	Outperform Votes 9 50.00%	Underperform Votes 9 50.00%
CB Scientific	N/A	N/A

Summary

Surgalign beats CB Scientific on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CBSC vs. The Competition

Export to Excel

Metric	CB Scientific	Industry	Medical Sector	OTCMKTS Exchange
Market Cap	$22.71M	$1.91B	$4.18B	$6.35B
Dividend Yield	N/A	15.72%	7.99%	37.38%
P/E Ratio	N/A	2.02	91.21	2.13
Price / Sales	N/A	351.81	3,328.79	563.33
Price / Cash	N/A	100.78	20.89	17.99
Price / Book	N/A	1.20	5.92	6.42
Net Income	N/A	$915.89M	$162.61M	$746.35M
7 Day Performance	-4.04%	2.23%	4.13%	0.62%
1 Month Performance	-23.97%	-3.81%	-6.68%	-5.30%
1 Year Performance	-12.44%	-14.54%	-34.42%	69.92%

CB Scientific Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRGA Surgalign	1.9388 of 5 stars	$3.50 +1.4%	$47.50 +1,257.1%	-88.8%	$23.61M	$90.50M	-0.28	231	Gap Up
ONCR Oncorus	2.2461 of 5 stars	$0.91 +3.4%	$7.75 +750.8%	-90.9%	$23.58M	N/A	-0.32	82	Gap Up
BCAC Brookline Capital Acquisition	0 of 5 stars	$3.47 -15.8%	N/A	N/A	$23.41M	N/A	0.00	6	Gap Down High Trading Volume
EFTR eFFECTOR Therapeutics	2.6475 of 5 stars	$0.56 flat	$11.30 +1,903.2%	-95.7%	$23.38M	$1.43M	0.74	12	Positive News Gap Up
ATNF 180 Life Sciences	0 of 5 stars	$0.70 +2.9%	N/A	-87.6%	$23.96M	N/A	1.67	2	Positive News
ATBPF Antibe Therapeutics	0 of 5 stars	$0.45 flat	N/A	-50.7%	$23.35M	$7.67M	0.00	47	Short Interest ↓ Positive News
TNXP Tonix Pharmaceuticals	2.1922 of 5 stars	$0.54 +1.9%	$19.20 +3,484.8%	-97.1%	$23.99M	N/A	-0.08	73	News Coverage Positive News Gap Up
ACER Acer Therapeutics	2.1041 of 5 stars	$1.45 +7.4%	$12.00 +727.6%	-44.3%	$23.12M	$1.26M	-1.07	35	Short Interest ↑ News Coverage Positive News Gap Up
ALRT ALR Technologies	0 of 5 stars	$0.04 flat	N/A	-34.5%	$23.07M	$10,000.00	0.00	1
RGRX RegeneRx Biopharmaceuticals	0 of 5 stars	$0.16 +6.7%	N/A	+0.3%	$22.97M	$80,000.00	0.00	3

This page (OTCMKTS:CBSC) was last updated on 10/4/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms